Loading company…
Medexus Pharmaceuticals Inc. develops therapeutics for autoimmune diseases and pediatrics, with products including EpiCeram and Otixal.
Founded in 2007 and based in Montreal, Canada, Medexus Pharmaceuticals Inc., formerly known as Pediapharm Inc., develops treatments for autoimmune diseases and pediatric conditions. Its products include EpiCeram for atopic dermatitis, NYDA for head lice, Otixal for acute otitis media with tympanostomy tubes, Relaxa for occasional constipation, Rupall for allergic rhinitis, and CUVPOSA for chronic severe drooling in patients aged 3 to 18. The company is listed at Public stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in